All lobbying filings

CHAMBER HILL STRATEGIES

CHAMBER HILL STRATEGIES filed a Q3 report for OS THERAPIES on October 19, 2026.

Lobbying for OS THERAPIES · biotechnology company

All filings by CHAMBER HILL STRATEGIES · Everything OS THERAPIES has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New York

Official filing document

Lobbyists on this filing 3

JENNIFER BELL

Previously held: Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Rep. John Thune (R-SD)
SHAWN FRIESEN

Previously held: Legislative Director, Rep. Mac Collins (R-GA)); Legislative Assistant, Rep. Tom Ewing (IL-15); Clerk, House Judiciary Committee
JENNIFER HOLLAND

Previously held: Scheduler, Rep. Mary Kaptur (OH-09); Operations Director, Rep. Donald Norcross (NJ-01); Scheduler, Rep. Debbie Dingell (MI-06)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Pharmacy

cancer immunotherapy and antibody treatment; osteosarcoma

Health Issues

cancer immunotherapy and antibody treatment; osteosarcoma

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.